Skip to main content
Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.380
+0.090 (2.74%)
At close: Mar 9, 2026, 4:00 PM EDT
3.420
+0.040 (1.18%)
After-hours: Mar 9, 2026, 4:41 PM EDT

Exagen Revenue

Exagen had revenue of $17.24M in the quarter ending September 30, 2025, with 37.87% growth. This brings the company's revenue in the last twelve months to $63.60M, up 14.08% year-over-year. In the year 2024, Exagen had annual revenue of $55.64M with 5.89% growth.

Revenue (ttm)
$63.60M
Revenue Growth
+14.08%
P/S Ratio
1.17
Revenue / Employee
$295,809
Employees
215
Market Cap
76.60M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202455.64M3.09M5.89%
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 202041.98M1.59M3.93%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Myriad Genetics 824.50M
Inotiv 514.03M
Fulgent Genetics 322.67M
MDxHealth 107.88M
FONAR 106.03M
Prenetics Global 92.39M
Biodesix 88.50M
Burning Rock Biotech 75.75M
Revenue Rankings

XGN News

More News